Go to the list of all blogs
Allana's Avatar
published in Blogs
Aug 23, 2026
Sabesp (SBS) Slides -17.8% Over 30 Days: Key Factors Behind the Move

Sabesp (SBS) Slides -17.8% Over 30 Days: Key Factors Behind the Move

Key Takeaways

  • SBS shares fell roughly 17.8% over the last 30 days, sliding from about $5.61 to $4.61.
  • The sharpest leg lower followed second-quarter 2026 results, which missed revenue and earnings consensus.
  • Rising operating costs, a contracting EBITDA margin, and a higher net-debt load pressured profitability.
  • The ADR remains well below its 52-week high of $7.16, reached in April 2026.
  • Heavy capital spending, rising leverage, and Brazilian macro and currency volatility continue to weigh on sentiment.

Sabesp (SBS) Company Overview and Market Position

Companhia de Saneamento Básico do Estado de São Paulo, widely known as SBS, is Brazil's largest water and sewage utility. The company supplies treated water, sewage collection and treatment, and related sanitation services across hundreds of municipalities in São Paulo state, serving tens of millions of residential, commercial, and industrial customers. Following its landmark privatization in mid-2024, SBS operates under private control, with a strategy centered on universal sanitation coverage, infrastructure expansion, and operational efficiency. Investors follow the stock for its regulated, essential-services business model, its heavy multi-year investment program, and its exposure to Brazil's interest-rate and currency environment.

Sabesp (SBS) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, SBS declined approximately 17.8%, from a closing price near $5.61 to $4.61. The downturn was not linear: the stock recorded its sharpest single-session decline of the period in mid-August, falling about 7.1% on above-average volume immediately after the company's second-quarter earnings release. The move extended a longer retreat from the ADR's 52-week high of $7.16, set in April 2026, leaving the shares roughly one-third below that peak.

Looking at the broader quarter, the trend has been similarly negative. The stock has shed roughly 18.5% over the trailing three months, reflecting a steady repricing after a strong rally earlier in the year. The persistent decline suggests the market has been recalibrating expectations around profitability, leverage, and the company's ambitious capital-expenditure cycle rather than reacting to a single isolated event. I also checked this using Tickeron’s AI Pattern Search Engine to confirm recent price behavior.

What Drove SBS Stock Price in the Last 30 Days

The dominant catalyst was Sabesp's second-quarter 2026 earnings report, released in mid-August. The company's ADR results came in below consensus: revenue of approximately $1.18 billion fell short of the roughly $1.33 billion expected, while adjusted earnings per share narrowly missed estimates. In Brazilian-real terms, reported net income declined 31.4% year over year, and adjusted net income fell 41.2%. Adjusted EBITDA contracted 3.2%, with the EBITDA margin narrowing from 64% to 58% as cost pressures mounted.

Several factors explain the deterioration. Chemical costs rose about 20% on average, power charges increased, and milder weather reduced water production and consumption. A 9.9% tariff increase was not enough to offset a roughly 24.5% rise in costs. Meanwhile, net debt climbed from R$23 billion to R$34 billion as the company funded its universal-access investment program, driving higher financial expenses. Elevated selling volume on down days indicated that the repricing carried genuine conviction, and a subsequent ratings downgrade added to the cautious tone.

What Drove SBS Stock Performance Over the Last Quarter

The quarterly decline reflects a broader narrative shift rather than a single headline. After a strong run into early 2026, SBS began giving back gains as investors reassessed valuation. An analyst downgrade to Neutral in May cited valuation concerns after the stock's substantial appreciation. Around the same period, Sabesp's involvement as lead bidder in a privatization auction for a strategic stake in a peer utility raised questions about future capital-spending needs and regulatory risk. Combined with a heavy multi-year investment plan and rising leverage, these developments eroded confidence in near-term cash conversion and payout flexibility, even as the company's core operations continued to generate solid cash flow.

SBS Stock Forecast Drivers: What Investors Should Watch Next

Investors should monitor several factors that could shape SBS in the coming quarters. Earnings execution and guidance updates remain central, particularly whether management can deliver on its roughly R$20 billion 2026 investment plan while stabilizing margins. Leverage trends are equally important, with net debt to adjusted EBITDA near 2.5x and most debt indexed to Brazil's CDI rate. Tariff reviews and the regulatory recognition of costs, including the expected recovery of some second-quarter revenue timing effects, will influence profitability. Continued cost inflation in chemicals and power, progress on the universal-access program, and any updates on strategic partnerships or privatization-related synergies also warrant attention. Broader macro factors, including Brazilian interest rates, the real's exchange rate, and sector rotation within utilities, will continue to affect the ADR's valuation. From what I see, these elements remain the main variables to track closely.

Exploring Systematic Strategies for Names Like SBS

When evaluating volatile names like SBS, I sometimes review Tickeron's Trending AI Robots to see how different automated approaches have performed across similar market conditions. The page highlights top bots with varying strategies and timeframes, which can help match tools to personal risk preferences without replacing core fundamental analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SBS

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


SBS sees MACD Histogram just turned negative

SBS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 21, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SBS as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SBS moved below its 50-day moving average on July 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SBS crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SBS entered a downward trend on August 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

SBS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.859) is normal, around the industry mean (7.003). P/E Ratio (10.050) is within average values for comparable stocks, (25.836). SBS's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.702). SBS has a moderately low Dividend Yield (0.007) as compared to the industry average of (0.032). P/S Ratio (2.049) is also within normal values, averaging (6.026).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

Industry description

Water utilities operate water treatment plants, and/or distribute water to residential and commercial customers. Companies operating in this industry are largely responsible for the safe and timely distribution of water. While most water systems are local or regional, some of the companies might have operations across several states. The industry is expected to be closely monitored by regulators for quality checks on the water being distributed. Investing in upgrading infrastructure is a major factor in bolstering the supply of clean/safe-to-use water. Given the absolute necessity of water in our lives, the industry is largely non-cyclical. American Water Works Company, Inc., Aqua America, Inc., American States Water Co. and California Water Service Group are some of the major water utilities companies in the U.S.

Market Cap

The average market capitalization across the Water Utilities Industry is 5.15B. The market cap for tickers in the group ranges from 41.88K to 26.91B. AWK holds the highest valuation in this group at 26.91B. The lowest valued company is AEPT at 41.88K.

High and low price notable news

The average weekly price growth across all stocks in the Water Utilities Industry was 0%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 3%. CDZI experienced the highest price growth at 5%, while CWCO experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Water Utilities Industry was 7%. For the same stocks of the Industry, the average monthly volume growth was 76% and the average quarterly volume growth was 83%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 70
P/E Growth Rating: 46
Price Growth Rating: 49
SMR Rating: 76
Profit Risk Rating: 86
Seasonality Score: -47 (-100 ... +100)
View a ticker or compare two or three
SBS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an operator of water, sewage and industrial wastewater systems

Industry WaterUtilities

Profile
Details
Industry
Water Utilities
Address
Rua Costa Carvalho, 300
Phone
+55 1133888247
Employees
11170
Web
https://www.sabesp.com.br
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.